Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Return on Assets: 2013-2025

Historic Return on Assets for Enanta Pharmaceuticals (ENTA) over the last 13 years, with Sep 2025 value amounting to -0.28%.

  • Enanta Pharmaceuticals' Return on Assets rose 2.00% to -0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.28%, marking a year-over-year increase of 2.00%. This contributed to the annual value of -0.25% for FY2025, which is 3.00% up from last year.
  • According to the latest figures from Q3 2025, Enanta Pharmaceuticals' Return on Assets is -0.28%, which was up 4.47% from -0.29% recorded in Q2 2025.
  • Over the past 5 years, Enanta Pharmaceuticals' Return on Assets peaked at -0.19% during Q1 2021, and registered a low of -0.37% during Q1 2023.
  • For the 3-year period, Enanta Pharmaceuticals' Return on Assets averaged around -0.30%, with its median value being -0.29% (2025).
  • As far as peak fluctuations go, Enanta Pharmaceuticals' Return on Assets dropped by 23bps in 2021, and later rose by 6bps in 2024.
  • Quarterly analysis of 5 years shows Enanta Pharmaceuticals' Return on Assets stood at -0.26% in 2021, then decreased by 7bps to -0.33% in 2022, then climbed by 2bps to -0.31% in 2023, then climbed by 2bps to -0.29% in 2024, then grew by 2bps to -0.28% in 2025.
  • Its last three reported values are -0.28% in Q3 2025, -0.29% for Q2 2025, and -0.29% during Q1 2025.